Market Overview
The inhalation and nasal spray generic drugs market is experiencing chronic respiratory disease emphasis where generic asthma and COPD medications enable disease control and exacerbation prevention in 500+ million patients globally. The inhalation and nasal spray generic drugs market is projected to exceed USD 8.4 billion through 2030, with chronic disease emphasis driven...
Bangla